Consensus DaShenLin Pharmaceutical Group Co., Ltd.

Equities

603233

CNE100002RG2

End-of-day quote Shanghai S.E. 07:00:00 2024-03-27 pm EDT 5-day change 1st Jan Change
21.11 CNY +0.19% Intraday chart for DaShenLin Pharmaceutical Group Co., Ltd. -3.03% -15.22%

Evolution of the average Target Price on DaShenLin Pharmaceutical Group Co., Ltd.

Price target over the last 5 years

History of analyst recommendation changes

8cbf84e9.R8-NAwhreqSKnXRu2Hy3PCar2C7f2ONSNQdWAisoJB0.fpXiTjsnFpHzxBE9oRPeeW_563eAmdIxBnduR0B6VHEevOBoeB4I59XoRA~e7f6a9a80a236af90be668f028efa373

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
15
Last Close Price
21.11 CNY
Average target price
33.76 CNY
Spread / Average Target
+59.94%
High Price Target
38 CNY
Spread / Highest target
+80.01%
Low Price Target
28.9 CNY
Spread / Lowest Target
+36.90%

Consensus detail

Consensus revision (last 18 months)

Analysts covering DaShenLin Pharmaceutical Group Co., Ltd.

UBS
Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings